Your session is about to expire
← Back to Search
Study Summary
This trial will test if Epidiolex, a drug containing cannabidiol, is effective in treating patients with ESES.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have used cannabidiol in the last 4 months.I have not had a fever or febrile illness in the last month.You have smoked or used tobacco in the last 6 months.I am allergic to Epidiolex, sesame seed oil, or sucralose.I am a man who can father children and will use contraception.I am between 2 and 17 years old.I can take pills and will follow the medication plan.
- Group 1: IP
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this investigation still accepting participants?
"Indeed, the clinicaltrial.gov listing confirms that this medical trial is currently enrolling participants. It was initially published on March 10th 2021 and most recently edited on April 5th 2022. The research team requires a total of 34 individuals from one site to participate in the study."
How many participants are enrolled in this clinical research?
"Affirmative. Information located on clinicaltrials.gov confirms that this experiment, which was posted initially on March 10th 2021, is currently enrolling participants. Approximately 34 individuals need to be enrolled from 1 medical centre."
What prior studies have been conducted on the utility of IP?
"Presently, 79 clinical trials for IP are ongoing. Of these studies, 16 have reached Phase 3 and 290 distinct sites are running the trial globally with a focus in Ribeirao Preto and Sao Paulo."
Are there any health risks associated with IP treatment?
"Our experts at Power rated IP's safety as a 1, indicating that there is limited evidence of its efficacy and it has yet to be well-tested."
Is there an opportunity to be involved in this clinical experiment?
"This research initiative is in search of 34 participants between the ages of two and seventeen who have been diagnosed with petit mal status. In addition to being willing and able to comply with study procedures, potential candidates should possess general health stability without any imminently requiring hospitalization due to seizures, alongside a signed consent form. For male or female patients of reproductive age, they must utilize an approved birth control method one month prior to screening as well as throughout their participation in the trial; males are additionally mandated use condoms during sexual intercourse for contraceptive purposes."
Is the participant eligibility for this experiment limited to individuals over 60 years of age?
"The age range for this medical trial is between 2 and 17, as dictated by the eligibility criteria."
Share this study with friends
Copy Link
Messenger